Understanding preferences for type of take-home naloxone device: international qualitative analysis of the views of people who use opioids

References

• Barnum, C. M. (2011). Usability testing essentials. Ready, set… test!. Morgan Kaufmann, Elsvier Inc.
   Google Scholar
• Bate, P., & Robert, G. (2007). Bringing user experience to healthcare improvement: The concepts, methods and practices of experience-based design. Radcliffe Publishing.
   Google Scholar
• Behar, E., Bagnulo, R., & Coffin, P. (2018). Acceptability and feasibility of naloxone prescribing in primary care settings: A systematic review. Preventive Medicine, 114(September), 79–87. https://doi.org/https://doi.org/10.1016/j.ypmed.2018.06.005
   PubMedGoogle Scholar
• Belk, R. W. (1975). The objective situation as a determinant of consumer behavior. Advances in Consumer Research, 2, 427–438.
   Google Scholar
• Black, L., Connolly, I., Getty, M., Hogan, C., Lennon, P., Mc Cusker, M., Neale, J., & Strang, J. (2017). Poor implementation of naloxone needs to be better understood in order to save lives. Addiction, 112(5), 911–912. https://doi.org/https://doi.org/10.1111/add.13778
   PubMed Web of Science ®Google Scholar
• Bowen, S., McSeveny, K., Lockley, E., Wolstenholme, D., Cobb, M., & Dearden, A. (2013). How was it for you? Experiences of participatory design in the UK health service. CoDesign, 9(4), 230–246. https://doi.org/https://doi.org/10.1080/15710882.2013.846384
   Web of Science ®Google Scholar
• Boyd, H., McKernon, S., Mullin, B., & Old, A. (2012). Improving healthcare through the use of co-design. The New Zealand Medical Journal, 125(1357), 76–87.
   PubMedGoogle Scholar
• Clarke, S. F., Dargan, P. L., & Jones, A. L. (2005). Naloxone in opioid poisoning: Walking the tightrope. Emergency Medicine Journal: EMJ, 22(9), 612–616. https://doi.org/https://doi.org/10.1136/emj.2003.009613
   PubMed Web of Science ®Google Scholar
• Cohen, B. R., Mahoney, K. M., Baro, E., Squire, C., Beck, M., Travis, S., Pike-McCrudden, A., Izem, R., & Woodcock, J. (2020). FDA initiative for drug facts label for over-the-counter naloxone. New England Journal of Medicine, 382(22), 2129–2136. https://doi.org/https://doi.org/10.1056/NEJMsa1912403
   PubMed Web of Science ®Google Scholar
• Cruz-Cárdenas, J., & Arévalo-Chávez, P. (2018). Consumer behavior in the disposal of products: Forty years of research. Journal of Promotion Management, 24(5), 617–636. https://doi.org/https://doi.org/10.1080/10496491.2018.1405514
   Google Scholar
• Davis, C. S., & Carr, D. (2015). Legal changes to increase access to naloxone for opioid overdose reversal in the United States. Drug and Alcohol Dependence, 157(December), 112–120. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2015.10.013
   PubMedGoogle Scholar
• Dietze, P., Cogger, S., Malandkar, D., Olsen, A., & Lenton, S. (2015). Knowledge of naloxone and take-home naloxone programs among a sample of people who inject drugs in Australia (Illicit Drugs Reporting System Drug Trends Bulletin April 2015). National Drug and Alcohol Research Centre, UNSW.
   Google Scholar
• Dietze, P., Jauncey, M., Salmon, A., Mohebbi, M., Latimer, J., van Beek, I., McGrath, C., & Kerr, D. (2019). Effect of intranasal vs intramuscular naloxone on opioid overdose: A randomized clinical trial. JAMA Network Open, 2(11), e1914977. https://doi.org/https://doi.org/10.1001/jamanetworkopen.2019.14977
   PubMed Web of Science ®Google Scholar
• DiMasi, J. A. (2002). The value of improving the productivity of the drug development process. Faster times and better decisions. PharmacoEconomics, 20(Supplement 3), 1–10. https://doi.org/https://doi.org/10.2165/00019053-200220003-00001
   PubMedGoogle Scholar
• Dumas, J. S., & Redish, J. C. (1999). A practical guide to usability testing (Revised ed.). Intellect Books.
   Google Scholar
• Dunn, K. E., Barrett, F. S., & Bigelow, G. E. (2018). Naloxone formulation for overdose reversal preference among patients receiving opioids for pain management. Addictive Behaviors, 86(November), 56–60. https://doi.org/https://doi.org/10.1016/j.addbeh.2018.03.011
   PubMedGoogle Scholar
• Dwyer, R., Fraser, S., & Dietze, P. (2016). Benefits and barriers to expanding the availability of take-home naloxone in Australia: A qualitative study. Drugs: Education, Prevention and Policy, 23(5), 388–396. https://doi.org/https://doi.org/10.3109/09687637.2016.1150964
   Web of Science ®Google Scholar
• Engel, J. F., Kollat, D. T., & Blackwell, R. D. (1969). Personality measures and market segmentation. Business Horizons, 12(3), 61–70. https://doi.org/https://doi.org/10.1016/0007-6813(69)90009-3
   Web of Science ®Google Scholar
• Farrugia, A., Fraser, S., Dwyer, R., Fomiatti, R., Neale, J., Dietze, P., & Strang, J. (2019). Take-home naloxone and the politics of care. Sociology of Health and Illness, 41(2), 427–443. https://doi.org/https://doi.org/10.1111/1467-9566.12848
   PubMed Web of Science ®Google Scholar
• Farrugia, A., Neale, J., Dwyer, R., Fomiatti, R., Fraser, S., Strang, J., & Dietze, P. (2020). Conflict and communication: Managing the multiple affordances of take-home naloxone administration events in Australia. Addiction Research & Theory, 28(1), 29–37. https://doi.org/https://doi.org/10.1080/16066359.2019.1571193
   Web of Science ®Google Scholar
• Fennell, G. (1978). Consumers' perceptions of the product-use situation. A conceptual framework for identifying consumer wants and formulating positioning options. Journal of Marketing, 42(April), 38–47.
   Google Scholar
• Fomiatti, R., Farrugia, A., Dwyer, R., Fraser, S., Neale, J., & Strang, J. (2020). Addiction stigma and the production of impediments to take-home naloxone uptake. Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine. https://doi.org/https://doi.org/10.1177/1363459320925863
   Google Scholar
• Food and Drug Administration. (n.d). Having naloxone on hand can save a life during opioid overdose. https://www.fda.gov/consumers/consumer-updates/having-naloxone-hand-can-save-life-during-opioid-overdose
   Google Scholar
• Fuchs, C., & Schreier, M. (2011). Customer empowerment in new product development. Journal of Product Innovation Management, 28(1), 17–32. https://doi.org/https://doi.org/10.1111/j.1540-5885.2010.00778.x
   Web of Science ®Google Scholar
• Gad, S. C. (2017). Drug safety evaluation. John Wiley & Sons, Inc.
   Google Scholar
• Gemser, G., & Perks, H. (2015). Co-creation with customers: An evolving innovation research field. Journal of Product Innovation Management, 32(5), 660–665. https://doi.org/https://doi.org/10.1111/jpim.12279
   Web of Science ®Google Scholar
• Green, T. C., Case, P., Fiske, H., Baird, J., Cabral, S., Burstein, D., Schwartz, V., Potter, N., Walley, A. Y., & Bratberg, J. (2017). Perpetuating stigma or reducing risk? Perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states. Journal of the American Pharmacists Association: JAPHA, 57(2S), S19–S27. https://doi.org/https://doi.org/10.1016/j.japh.2017.01.013
   PubMedGoogle Scholar
• Jones, E. E., & Harris, V. A. (1967). The attribution of attitudes. Journal of Experimental Social Psychology, 3(1), 1–24. https://doi.org/https://doi.org/10.1016/0022-1031(67)90034-0
   Web of Science ®Google Scholar
• Kelly, A.-M., Kerr, D., Dietze, P., Patrick, I., Walker, T., & Koutsogiannis, Z. (2005). Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose. The Medical Journal of Australia, 182(1), 24–27. https://doi.org/https://doi.org/10.5694/j.1326-5377.2005.tb06550.x
   PubMed Web of Science ®Google Scholar
• Kerensky, T., & Walley, A. Y. (2017). Opioid overdose prevention and naloxone rescue kits: What we know and what we don’t know. Addiction Science and Clinical Practice, 12(1), 4. https://doi.org/https://doi.org/10.1186/s13722-016-0068-3
   PubMedGoogle Scholar
• Kerr, D., Dietze, P., Kelly, A.-M., & Jolley, D. (2008). Attitudes of Australian heroin users to peer distribution of naloxone for heroin overdose: Perspectives on intranasal administration. Journal of Urban Health: bulletin of the New York Academy of Medicine, 85(3), 352–360. https://doi.org/https://doi.org/10.1007/s11524-008-9273-z
   PubMed Web of Science ®Google Scholar
• Kerr, D., Kelly, A. M., Dietze, P., Jolley, D., & Barger, B. (2009). Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose. Addiction, 104(12), 2067–2074. https://doi.org/https://doi.org/10.1111/j.1360-0443.2009.02724.x
   PubMed Web of Science ®Google Scholar
• Krieter, P., Chiang, N., Gyaw, S., Skolnick, P., Crystal, R., Keegan, F., Aker, J., Beck, M., & Harris, J. (2016). Pharmacokinetic properties and human use characteristics of an FDA-approved intranasal naloxone product for the treatment of opioid overdose. Journal of Clinical Pharmacology, 56(10), 1243–1253. https://doi.org/https://doi.org/10.1002/jcph.759
   PubMed Web of Science ®Google Scholar
• Lackey, N. R., & Gates, M. F. (1997). Combining the analyses of three qualitative data sets in studying young caregivers. Journal of Advanced Nursing, 2(4), 664–671.
   Google Scholar
• Lagu, T., Anderson, B., & Stein, M. (2006). Overdoses among friends: Drug users are willing to administer naloxone to others. Journal of Substance Abuse Treatment, 30(2), 129–133. https://doi.org/https://doi.org/10.1016/j.jsat.2005.05.010
   PubMed Web of Science ®Google Scholar
• Lankenau, S., Wagner, K., Silva, K., Kecojevic, A., Iverson, E., McNeely, M., 7., & Kral, A. (2013). Injection drug users trained by overdose prevention programs: Responses to witnessed overdoses. Journal of Community Health, 38(1), 133–141. https://doi.org/https://doi.org/10.1007/s10900-012-9591-7
   PubMed Web of Science ®Google Scholar
• Mahr, D., Lievens, A., & Blazevic, V. (2014). The value of customer cocreated knowledge during the innovation process. Journal of Product Innovation Management, 31(3), 599–615. https://doi.org/https://doi.org/10.1111/jpim.12116
   Web of Science ®Google Scholar
• Martins, S. S., Sampson, L., Cerdá, M., & Galea, S. (2015). Worldwide prevalence and trends in unintentional drug overdose: A systematic review of the literature. American Journal of Public Health, 105(11), e29–e49. https://doi.org/https://doi.org/10.2105/AJPH.2015.302843
   PubMed Web of Science ®Google Scholar
• McAuley, A., Munro, A., & Taylor, A. (2018). Once I’d done it once it was like writing your name”: Lived experience of take-home naloxone administration by people who inject drugs. International Journal of Drug Policy, 58, 46–54. https://doi.org/https://doi.org/10.1016/j.drugpo.2018.05.002
   PubMed Web of Science ®Google Scholar
• McDonald, R., Campbell, N., & Strang, J. (2017). Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-Conception and maturation. Drug and Alcohol Dependence, 178(September), 176–187. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2017.05.001
   PubMedGoogle Scholar
• McDonald, R., Lorch, U., Woodward, J., Bosse, B., Dooner, H., Mundin, G., Smith, K., & Strang, J. (2018). Pharmacokinetics of concentrated naloxone nasal spray for opioid overdose reversal: Phase I healthy volunteer study. Addiction, 113(3), 484–493. https://doi.org/https://doi.org/10.1111/add.14033
   PubMed Web of Science ®Google Scholar
• Mitchell, E. S. (1986). Multiple triangulation: A methodology for nursing science. ANS. Advances in Nursing Science, 8(3), 18–26. https://doi.org/https://doi.org/10.1097/00012272-198604000-00004
   PubMed Web of Science ®Google Scholar
• Mitchell, K. D., & Higgins, L. J. (2016). Combating opioid overdose with public access to naloxone. Journal of Addictions Nursing, 27(3), 160–179. https://doi.org/https://doi.org/10.1097/JAN.0000000000000132
   PubMed Web of Science ®Google Scholar
• Mowen, J. C. (1995). Consumer behaviour. Prentice-Hall.
   Google Scholar
• Mueller, S. R., Walley, A. Y., Calcaterra, S. L., Glanz, J. M., & Binswanger, I. A. (2015). A review of opioid overdose prevention and naloxone prescribing: Implications for translating community programming into clinical practice. Substance Abuse, 36(2), 240–253. https://doi.org/https://doi.org/10.1080/08897077.2015.1010032
   PubMed Web of Science ®Google Scholar
• Neale, J., & Strang, J. (2015). Naloxone-does over-antagonism matter? Evidence of iatrogenic harm after emergency treatment of heroin/opioid overdose. Addiction (Abingdon, England)), 110(10), 1644–1652. https://doi.org/https://doi.org/10.1111/add.13027
   PubMed Web of Science ®Google Scholar
• Neale, J. (2016). Iterative categorization (IC): A systematic technique for analysing qualitative data. Addiction, 111(6), 1096–1106. https://doi.org/https://doi.org/10.1111/add.13314
   PubMed Web of Science ®Google Scholar
• Neale, J., Brown, C., Campbell, A. N. C., Jones, J. D., Metz, V. E., Strang, J., & Comer, S. D. (2019). How competent are people who use opioids at responding to overdoses? Qualitative analyses of actions and decisions taken during overdose emergencies. Addiction, 114(4), 708–718. https://doi.org/https://doi.org/10.1111/add.14510
   PubMed Web of Science ®Google Scholar
• Neale, J., Kalk, N. J., Parkin, S., Brown, C., Brandt, L., Campbell, A. M. C., Castillo, F., Jones, J. D., Strang, J., & Comer, S. D. (2020). Factors associated with withdrawal symptoms and anger among people resuscitated from an opioid overdose by take-home naloxone: Exploratory mixed methods analysis. Journal of Substance Abuse Treatment, 117, 108099. https://doi.org/https://doi.org/10.1016/j.jsat.2020.108099
   PubMed Web of Science ®Google Scholar
• Neale, J. (2020). Iterative categorisation (part 2): Interpreting qualitative data. Addiction, https://doi.org/https://doi.org/10.1111/add.15259 [online ahead of print].
   Google Scholar
• Patton, M. Q. (1999). Enhancing the quality and credibility of qualitative analysis. Health Services Research, 34(5 Pt 2), 1189–1208.
   PubMed Web of Science ®Google Scholar
• Richert, T. (2015). Wasted, overdosed, or beyond saving-to act or not to act? Heroin users' views, assessments, and responses to witnessed overdoses in Malmö, Sweden. International Journal of Drug Policy, 26(1), 92–99. https://doi.org/https://doi.org/10.1016/j.drugpo.2014.07.006
   PubMed Web of Science ®Google Scholar
• Rosenthal, R. N., Ling, W., Casadonte, P., Vocci, F., Bailey, G. L., Kampman, K., Patkar, A., Chavoustie, S., Blasey, C., Sigmon, S., & Beebe, K. L. (2013). Buprenophine implants for treatment of opioid dependence: Randomized comparison to placebo and sublingual buprenorphine/naloxone. Addiction, 108(12), 2141–2149. https://doi.org/https://doi.org/10.1111/add.12315
   PubMed Web of Science ®Google Scholar
• Ross, L. (1977). The intuitive psychologist and his shortcomings: Distortions in the attribution process. In L. Berkowitz (Ed.), Advances in experimental social psychology (pp. 173–220).Academic Press.
   Google Scholar
• Roxburgh, A., Dobbins, T., Degenhardt, L., Peacock, A. (2018). Opioid, amphetamine, and cocaine-induced deaths in Australia. 2018. National Drug and Alcohol Research Centre. https://ndarc.med.unsw.edu.au/resource/opioid-amphetamine-and-cocaine-induced-deaths-australia-august-2018
   Google Scholar
• Sandell, R. G. (1968). Effects of attitudinal and situational factors on reported choice behavior. Journal of Marketing Research, 5(4), 405–408. https://doi.org/https://doi.org/10.1177/002224376800500407
   Web of Science ®Google Scholar
• Skulberg, A. K., Asberg, A., Khiabani, H. Z., Rostad, H., Tylleskar, I., & Dale, O. (2019). Pharmacokinetics of a novel, approved, 1.4-mg intranasal naloxone formulation for reversal of opioid overdose-a randomized controlled trial. Addiction, 114(5), 859–867. https://doi.org/https://doi.org/10.1111/add.14552
   PubMed Web of Science ®Google Scholar
• Sporer, K. A., Firestone, J., & Isaacs, S. M. (1996). Out-of-hospital treatment of opioid overdoses in an urban setting. Academic Emergency Medicine, 3(7), 660–667. https://doi.org/https://doi.org/10.1111/j.1553-2712.1996.tb03487.x
   PubMed Web of Science ®Google Scholar
• Sporer, K. A. (1999). Acute heroin overdose. Annals of Internal Medicine, 130(7), 584–590. https://doi.org/https://doi.org/10.7326/0003-4819-130-7-199904060-00019
   PubMed Web of Science ®Google Scholar
• Srivastava, R. K., Shocker, A. D., & Day, G. S. (1978). An exploratory study of the influences of usage situation on perceptions of product-markets. Advances in Consumer Research, 5, 32–38.
   Google Scholar
• Stanton, J. L., & Bonner, P. G. (1980). An investigation of the differential impact of purchase situation on levels of consumer choice behavior. Advances in Consumer Research, 7, 639–643.
   Google Scholar
• Strang, J., Darke, S., Hall, W., Farrell, M., & Ali, R. (1996). Heroin overdose: The case for take-home naloxone. BMJ (Clinical Research ed), 312(7044), 1435–1446. https://doi.org/https://doi.org/10.1136/bmj.312.7044.1435
   PubMedGoogle Scholar
• Strang, J., McDonald, R., Alqurshi, A., Royall, P., Taylor, D., & Forbes, B. (2016). Naloxone without the needle - systematic review of candidate routes for non-injectable naloxone for opioid overdose reversal. Drug and Alcohol Dependence, 163(June), 16–23. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2016.02.042
   PubMedGoogle Scholar
• Strang, J., McDonald, R., Tas, B., & Day, E. (2016). Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: Imaginative shortcut or dangerous bypass of essential safety procedures? Addiction, 111(4), 574–582. https://doi.org/https://doi.org/10.1111/add.13209
   PubMed Web of Science ®Google Scholar
• Strang, J., McDonald, R., Campbell, G., Degenhardt, L., Nielsen, S., Ritter, A., & Dale, O. (2019). Take-Home naloxone for the emergency interim management of opioid overdose: The public health application of an emergency medicine. Drugs, 79(13), 1395–1418. https://doi.org/https://doi.org/10.1007/s40265-019-01154-5
   PubMed Web of Science ®Google Scholar
• Tylleskar, I., Skulberg, A. K., Nilsen, T., Skarra, S., Jansook, P., & Dale, O. (2017). Pharmacokinetics of a new, nasal formulation of naloxone. European Journal of Clinical Pharmacology, 73(5), 555–562. https://doi.org/https://doi.org/10.1007/s00228-016-2191-1
   PubMed Web of Science ®Google Scholar
• UK Medicines Information (UKMi). (2016). In use product safety assessment report: Naloxone products for emergency opiate reversal in non-medical settings. Specialist Pharmacy Service. https://www.sps.nhs.uk/articles/in-use-product-safety-assessment-report-naloxone-products-for-emergency-opiate-reversal-in-non-medical-settings
   Google Scholar
• US Department of Health and Human Services. (2019). What is the U.S. opioid epidemic? https://www.hhs.gov/opioids/about-the-epidemic/index.html
   Google Scholar
• Walley, A. Y., Xuan, Z., Hackman, H. H., Quinn, E., Doe-Simkins, M., Sorensen-Alawad, A., Ruiz, S., & Ozonoff, A. (2013). Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: Interrupted time series analysis. British Medical Journal, 30(January), 346:f174.
   Google Scholar
• Ward, S., & Robertson, T. S. (1973). Consumer behavior research: Promise and prospects. In S. Ward & T. S. Robertson (Eds.), Consumer behavior: Theoretical sources (pp. 3–42). Prentice-Hall.
   Google Scholar
• Weaver, L., Palombi, L., & Bastianelli, K. M. S. (2018). Naloxone administration for opioid overdose reversal in the prehospital setting: Implications for pharmacists. Journal of Pharmacy Practice, 31(1), 91–98. https://doi.org/https://doi.org/10.1177/0897190017702304
   PubMed Web of Science ®Google Scholar
• Williams, A. V., Marsden, J., & Strang, J. (2014). Training family members to manage heroin overdose and administer naloxone: Randomised trial of effects on knowledge and attitudes. Addiction, 109(2), 250–259. https://doi.org/https://doi.org/10.1111/add.12360
   PubMed Web of Science ®Google Scholar
• Winstanley, E. L., Clark, A., Feinberg, J., & Wilder, C. M. (2016). Barriers to implementation of opioid overdose prevention programs in Ohio. Substance Abuse, 37(1), 42–46. https://doi.org/https://doi.org/10.1080/08897077.2015.1132294
   PubMed Web of Science ®Google Scholar
• Worthington, N., Piper, T. M., Galea, S., & Rosenthal, D. (2006). Opiate users' knowledge about overdose prevention and naloxone in New York City: A focus group study. Harm Reduction Journal, 3(1), 19. https://doi.org/https://doi.org/10.1186/1477-7517-3-19
   PubMedGoogle Scholar